Back to search
FDAFDA · Food and drugs·Recall number D-0426-2018

Vecuronium bromide for Injection, 10 mg vials, Rx only, Mfd. for: Fresenius Kabi, Lake Zurich, IL 60047, Made in India, NDC 63323-781-10

Published February 7, 2018 · Recall initiated: January 16, 2018

Summary

FDA records drug Class III recall D-0426-2018, published February 7, 2018 and initiated January 16, 2018. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 35,620 vials; Lot: Lot #: ZG603, Exp 11/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/ degradation specifications: Out-of-specification (OOS) result for USP related compound F at the 12 month stability test station.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide USA
Lot
Lot #: ZG603, Exp 11/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vecuronium bromide for Injection, 10 mg vials, Rx only, Mfd. for: Fresenius Kabi, Lake Zurich, IL 60047, Made in India, NDC 63323-781-10 recalled?

Yes. FDA published recall D-0426-2018 on February 7, 2018. Reported hazard: Failed impurities/ degradation specifications: Out-of-specification (OOS) result for USP related compound F at the 12 month stability test station.

What should I do if I have this product?

Voluntary: Firm initiated · Letter